Disease burden
Showing 9976 - 10000 of >10,000
MIS-C Associated With COVID-19, COVID-19 Trial in Warsaw
Recruiting
- MIS-C Associated With COVID-19
- COVID-19
-
Warsaw, Masovian, PolandPediatric teaching clinical hospital, Warsaw Medical University
Sep 28, 2022
Monkeypox Trial (Tecovirimat Oral Capsule, Placebo)
Not yet recruiting
- Monkeypox
- Tecovirimat Oral Capsule
- Placebo
- (no location specified)
Nov 27, 2023
hsCAR and MAFLD: A Cross-sectional Study
Recruiting
- Metabolic Dysfunction-associated Fatty Liver Disease
- +2 more
- high-sensitivity C-reactive protein to albumin ratio
-
Chongqing, Chongqing, ChinaThe Second Affiliated Hospital of Chongqing Medical University
Aug 2, 2023
Food Allergy in Infants Trial in Shanghai (Bifidobacterium M-16V, allergy food avoidance)
Not yet recruiting
- Food Allergy in Infants
- Bifidobacterium M-16V
- allergy food avoidance
-
Shanghai, Shanghai, ChinaRuijin Hospital, Shanghai Jiaotong University School of Medicine
Aug 1, 2023
Disease-specific Questionnaire for Hirschsprung's Disease in
Completed
- Hirschsprung Disease
-
Odense, Region Syddanmark, DenmarkOdense University Hospital
Nov 8, 2022
An Observational Study of Patients With Autoimmune Disease
Not yet recruiting
- Autoimmune Diseases
- (no location specified)
Apr 24, 2023
Central Blood Pressure and Pulse Wave Velocity in Kidney
Recruiting
- End Stage Renal Disease
- there is no intervention
-
Washington, District of ColumbiaChildren's National Medical Cetner
Aug 26, 2022
MEDL Score,New Method for Evaluating Endometriosis Using MRI
Active, not recruiting
- Endometriosis
-
São Sebastião, São Paulo, BrazilClinica Medicina da Mulher
Oct 18, 2022
Coronary Artery Disease Trial in New York (Evolocumab Injections)
Recruiting
- Coronary Artery Disease
- Evolocumab Injections
-
New York, New YorkMount Sinai Hospital
May 13, 2021
SLE Trial (Blood test)
Not yet recruiting
- SLE
- Blood test
- (no location specified)
Jul 27, 2022
Wearable Assessments in the Clinic and Home in PD
Active, not recruiting
- Parkinson Disease
-
Sun City, Arizona
- +16 more
Mar 9, 2022
Alzheimer, Electric Stimulation Therapy Trial in Beijing (Cortical brain stimulation of mPFC and dlPFC)
Recruiting
- Alzheimer Disease
- Electric Stimulation Therapy
- Cortical brain stimulation of mPFC and dlPFC
-
Beijing, ChinaXuanwu Hospital
Jul 30, 2023
Sars-CoV2, Symptomatic Condition, Covid-19 Trial in Lahore (Hydroxychloroquine Sulfate Regular dose, Hydroxychloroquine Sulfate
Terminated
- Sars-CoV2
- +2 more
- Hydroxychloroquine Sulfate Regular dose
- +3 more
-
Lahore, Punjab, Pakistan
- +3 more
Mar 8, 2021
Endometriosis, Quality of Life Trial in Mulhouse (Physical activity, Physical activity and education)
Recruiting
- Endometriosis
- Quality of Life
- Physical activity
- Physical activity and education
-
Mulhouse, Escriva-Boulley, FranceUpper Alsace University
Apr 25, 2023
Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD)
Recruiting
- Fatty Liver Disease
- Fibrotouch
-
Beijing, Bejing, ChinaBejing Tsinghua Chang Gung Hospital
Jun 13, 2022
Exudative Macular Degeneration, Wet Age-related Macular Degeneration Trial in Iowa City (Doxycycline Hyclate, Placebo)
Recruiting
- Exudative Macular Degeneration
- Wet Age-related Macular Degeneration
- Doxycycline Hyclate
- Placebo
-
Iowa City, IowaUniversity of Iowa Hospitals & Clinics Department of Ophthalmolo
Apr 5, 2022
Longitudinal Study for Central Nervous System Vasculitis
Not yet recruiting
- Central Nervous System Vasculitis
- +3 more
-
Cleveland, Ohio
- +1 more
Feb 8, 2023
Hematopoietic Stem Cell Transplantation, Acute GVHD, Acute Myeloid Leukemia Trial in United States (CD24Fc, Placebo,
Terminated
- Hematopoietic Stem Cell Transplantation
- +4 more
- CD24Fc
- +3 more
-
Duarte, California
- +3 more
Oct 18, 2022
Hyperthyroidism, Osteoporosis, Osteoporosis Risk Trial (Patient Participation Form)
Not yet recruiting
- Hyperthyroidism
- +2 more
- Patient Participation Form
- (no location specified)
Feb 25, 2023
Hypothyroidism, Osteoporosis, Osteoporosis Risk Trial (Patient Participation Form)
Not yet recruiting
- Hypothyroidism
- +2 more
- Patient Participation Form
- (no location specified)
Feb 26, 2023
Osteoporosis, Osteoporosis Risk, Ankylosing Spondylitis Trial (Patient Participation Form)
Not yet recruiting
- Osteoporosis
- +2 more
- Patient Participation Form
- (no location specified)
Feb 26, 2023
Diabetes, Diabetes, Type 1, Diabetes, Type 2 Trial (Patient Participation Form)
Not yet recruiting
- Diabetes Mellitus
- +4 more
- Patient Participation Form
- (no location specified)
Feb 26, 2023
Multiple Sclerosis, Osteoporosis, Osteoporosis Risk Trial (Patient Participation Form)
Not yet recruiting
- Multiple Sclerosis
- +2 more
- Patient Participation Form
- (no location specified)
Feb 25, 2023
A Randomised Controlled Trial
Active, not recruiting
- Diabetes
- Chronic Kidney Diseases
- Minuteful Kidney Test Kit
-
Essex, United Kingdom
- +5 more
Jul 20, 2023
Pancreatic Tumors Trial in Shanghai (Sofantinib?abraxane?gemcitabine, Abraxane combined with gemcitabine)
Not yet recruiting
- Pancreatic Neoplasms
- Sofantinib、abraxane、gemcitabine
- Abraxane combined with gemcitabine
-
Shanghai, ChinaFudan University ShangHai Cancer Center
Jul 31, 2023